Ignite Creation Date:
2025-12-25 @ 5:19 AM
Ignite Modification Date:
2026-02-25 @ 8:31 PM
Study NCT ID:
NCT00097227
Status:
COMPLETED
Last Update Posted:
2010-04-09
First Post:
2004-11-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Trial of Carboplatin/Paclitaxel/Cetuximab in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)
Sponsor:
Eli Lilly and Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-11
Start Date Type:
None
Primary Completion Date:
2007-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-04
Completion Date Type:
ACTUAL
First Submit Date:
2004-11-18
First Submit QC Date:
None
Study First Post Date:
2004-11-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2010-04-08
Last Update Post Date:
2010-04-09
Last Update Post Date Type:
ESTIMATED